Shock mimikers

 

Is This Really Septic Shock – or Mimic? Vasculitis, Anaphylaxis, Adrenal Crisis, and Endocarditis Masquerading as Sepsis

Dr Neeraj Manikath, Claude.ai

Abstract

Background: Septic shock mimics present with identical clinical features including fever, tachycardia, tachypnea, and altered white blood cell count, creating diagnostic challenges that can lead to inappropriate management. The most common causes of distributive shock in the emergency department are sepsis and anaphylaxis, with neurogenic shock in trauma cases and less common causes including adrenal insufficiency.

Objective: To provide an evidence-based systematic approach to differentiating septic shock from its major mimics—vasculitis, anaphylaxis, adrenal crisis, and endocarditis—with emphasis on contemporary diagnostic strategies and management pearls for critical care practitioners.

Methods: Narrative review incorporating recent advances in sepsis biomarker research and clinical diagnostic criteria, with practical frameworks for emergency recognition and management.

Conclusions: Early recognition of sepsis mimics through systematic clinical assessment, targeted biomarker utilization, and understanding of distinct pathophysiologic patterns significantly improves patient outcomes and prevents inappropriate interventions.

Keywords: septic shock, vasculitis, anaphylaxis, adrenal crisis, endocarditis, distributive shock, biomarkers, critical care, emergency medicine

---

Introduction

Septic shock, defined by the Sepsis-3 consensus as sepsis with persistent hypotension requiring vasopressor support and serum lactate >2 mmol/L despite adequate fluid resuscitation, carries a mortality rate of 25-50% (1). However, the clinical constellation of distributive shock with systemic inflammatory response syndrome (SIRS) can be remarkably similar across multiple non-infectious etiologies, creating diagnostic dilemmas that challenge even experienced intensivists.

These sepsis mimics include anaphylaxis, gastrointestinal emergencies, pulmonary disease, metabolic abnormalities, toxin ingestion/withdrawal, vasculitis, and spinal injury—many of which can be deadly if not promptly diagnosed and managed. The challenge is compounded by the fact that anaphylactic shock and septic shock often have a component of hypovolemia as well, making hemodynamic differentiation difficult.

This comprehensive review examines four critical sepsis mimics that every critical care physician must recognize: systemic vasculitis, anaphylaxis, adrenal crisis, and infective endocarditis. We provide evidence-based diagnostic frameworks, contemporary biomarker insights, and management pearls to enhance clinical decision-making in these challenging scenarios.

---

The Diagnostic Challenge: Why Mimics Matter

A patient with a sepsis mimic will look just like a true septic patient with fever, tachycardia, tachypnea, and change in WBC, requiring initial resuscitation efforts to focus on the ABCs. The critical distinction lies in the subsequent management pathway, where misdiagnosis can lead to:

• Delayed appropriate therapy (e.g., epinephrine in anaphylaxis, corticosteroids in adrenal crisis)
• Inappropriate interventions (e.g., broad-spectrum antibiotics in vasculitis)
• Missed surgical opportunities (e.g., valve replacement in endocarditis)
• Increased morbidity and mortality from condition-specific complications

Contemporary Biomarker Landscape

Implementation of biomarkers in sepsis and septic shock in emergency situations remains highly challenging, with current obstacles impeding biomarker research in sepsis requiring novel avenues in biomarker discovery and implementation. Recent multicenter studies have assessed admission plasma levels of C-reactive protein, procalcitonin, adrenomedullin, proenkephalin, and dipeptidyl peptidase 3 to improve diagnostic accuracy.

---

Systemic Vasculitis: The Master of Disguise

Pathophysiology and Clinical Presentation

Systemic vasculitis represents inflammation of blood vessels that can affect any organ system, creating a clinical picture that closely mimics septic shock. The pathophysiology involves immune complex deposition, direct T-cell mediated vessel wall damage, and complement activation, resulting in:

• Vascular inflammation leading to increased permeability and distributive shock
• Organ-specific ischemia from vessel occlusion
• Systemic inflammatory response with fever, leukocytosis, and elevated acute phase reactants

Clinical Manifestations by System

Constitutional: Fever (>90%), malaise, weight loss, night sweats Cardiovascular: Hypotension, pericarditis, coronary arteritis, conduction abnormalities Respiratory: Pulmonary hemorrhage, interstitial pneumonitis, pleural effusionsRenal: Rapidly progressive glomerulonephritis, acute kidney injury, hematuria Neurologic: Stroke, mononeuritis multiplex, altered mental status, seizures Cutaneous: Palpable purpura, livedo reticularis, digital ischemia, splinter hemorrhages Gastrointestinal: Abdominal pain, GI bleeding, bowel ischemia

Diagnostic Pearls and Clinical Hacks

🔍 Pearl #1: The "Vasculitis Triad" - Simultaneous involvement of lungs, kidneys, and skin with negative blood cultures should trigger immediate ANCA testing and tissue biopsy consideration.

🦪 Oyster: Patients with vasculitis often have a prodromal phase of weeks to months with constitutional symptoms, unlike the acute onset typical of sepsis. Ask about: chronic fatigue, arthralgias, chronic sinusitis, or recurrent respiratory infections.

⚡ Clinical Hack: The "PANCA" mnemonic for vasculitis suspicion:

• Palpable purpura
• Acute kidney injury with hematuria
• Neurologic deficits (especially mononeuritis multiplex)
• Chronic constitutional symptoms
• Asymmetric organ involvement

Laboratory Differentiation

Parameter	Vasculitis	Sepsis	Clinical Significance
ANCA	Positive (60-95%)	Negative	c-ANCA/PR3 (GPA), p-ANCA/MPO (MPA, EGPA)
Complement (C3, C4)	Often low	Normal/elevated	Immune complex consumption
Eosinophils	Elevated (EGPA)	Normal/low	Especially >10% or >1500/μL
Procalcitonin	Normal/mildly elevated	Significantly elevated	<0.5 ng/mL suggests non-bacterial
Urinalysis	RBC casts, proteinuria	Variable	Glomerulonephritis pattern

🔍 Pearl #2: A procalcitonin <0.5 ng/mL in a patient with distributive shock should raise suspicion for non-infectious causes, particularly vasculitis.

Imaging Considerations

Chest CT: Look for pulmonary nodules, cavitary lesions, or alveolar hemorrhage Cardiac MRI: May reveal pericarditis or coronary arteritis Angiography: Essential for large vessel vasculitis (Takayasu, Giant Cell Arteritis)Echocardiography: Assess for pericardial effusion or valve involvement

Management Approach

🔍 Pearl #3: In suspected vasculitis with organ-threatening disease, do not delay immunosuppression pending tissue diagnosis. The window for reversible organ damage is narrow.

Initial Management:

1. High-dose corticosteroids: Methylprednisolone 1000 mg IV daily × 3 days
2. Cyclophosphamide: 2 mg/kg/day PO or 0.75 g/m² IV monthly for severe disease
3. Rituximab: Alternative to cyclophosphamide (375 mg/m² weekly × 4 weeks)
4. Plasmapheresis: Consider in pulmonary-renal syndrome or severe neurologic involvement

⚡ Clinical Hack: The "Rule of 3s" for vasculitis emergencies:

• Methylprednisolone 1000 mg × 3 days
• Cyclophosphamide within 3 days of diagnosis
• Tissue biopsy within 3 weeks if possible

---

Anaphylaxis: The Rapid Deceiver

Pathophysiology

Anaphylaxis represents a rapid-onset, multisystem allergic reaction mediated by IgE-dependent mast cell and basophil degranulation, leading to massive mediator release including histamine, leukotrienes, and cytokines. This creates distributive shock through:

• Vasodilation from histamine and nitric oxide release
• Increased vascular permeability leading to fluid extravasation
• Myocardial depression from inflammatory mediators
• Bronchospasm from leukotriene release

Clinical Presentation

🦪 Oyster: Up to 20% of anaphylactic reactions present without cutaneous manifestations, making diagnosis challenging in the critically ill patient.

Biphasic Anaphylaxis

🔍 Pearl #4: Biphasic anaphylaxis occurs in 3-20% of cases, with symptom recurrence 1-72 hours after apparent resolution. This can mimic sepsis progression or secondary infection.

Diagnostic Approach

Clinical Diagnosis: Anaphylaxis is primarily clinical, but laboratory confirmation can support the diagnosis:

Immediate (within 3 hours):

• Serum tryptase: Elevated in 60-90% of cases (normal <11.4 ng/mL)
• Plasma histamine: Elevated but rapidly metabolized (peak at 5-10 minutes)

Delayed (24-48 hours):

• 24-hour urine histamine metabolites: More stable marker
• Repeat tryptase: Should normalize if anaphylaxis (vs. mastocytosis)

⚡ Clinical Hack: The "FAST" assessment for anaphylaxis:

• Face: Angioedema, lip/tongue swelling, conjunctival injection
• Airway: Stridor, hoarseness, difficulty swallowing
• Stomach: Cramping, nausea, vomiting, diarrhea
• Total body: Hypotension, altered consciousness, skin changes

Management Distinctions

🔍 Pearl #5: Epinephrine is the cornerstone of anaphylaxis treatment, not fluid resuscitation. Delay in epinephrine administration is the primary cause of anaphylaxis mortality.

First-Line Treatment:

1. Epinephrine: 0.3-0.5 mg IM (or 0.1-0.5 mg IV if severe hypotension)
2. High-flow oxygen: Address potential airway compromise
3. IV fluids: Crystalloid for volume support
4. Antihistamines: H1 (diphenhydramine) and H2 (ranitidine) blockers
5. Corticosteroids: Methylprednisolone 1-2 mg/kg IV for biphasic prevention

Refractory Anaphylaxis Protocol:

• Epinephrine infusion: 0.1-1 mcg/kg/min IV
• Glucagon: 1-5 mg IV (especially if patient on beta-blockers)
• Vasopressin: 0.01-0.04 units/min IV
• Methylene blue: 1-2 mg/kg IV (for severe distributive shock)

⚡ Clinical Hack: If distributive shock doesn't respond to standard sepsis management and patient has recent allergen exposure, give empirical epinephrine while investigating—it can be diagnostic and therapeutic.

---

Adrenal Crisis: The Subtle Saboteur

Pathophysiology

Acute adrenal insufficiency may mimic overwhelming sepsis, with elevated cardiac output and low systemic vascular resistance in patients with known risk factors. The pathophysiology involves:

• Mineralocorticoid deficiency leading to sodium loss and hyperkalemia
• Glucocorticoid deficiency causing hypoglycemia and vascular hyporeactivity
• Loss of catecholamine responsiveness resulting in refractory hypotension

Clinical Presentation

🔍 Pearl #6: Adrenal crisis should be suspected in any patient with distributive shock that is remarkably refractory to high-dose vasopressors.

Classic Triad (Present in <50% of cases)

1. Hypotension (refractory to fluids and pressors)
2. Electrolyte abnormalities (hyponatremia, hyperkalemia)
3. Hypoglycemia

Risk Factors

• Chronic steroid use (most common—accounts for 70% of cases)
• Autoimmune adrenalitis (Addison's disease)
• Bilateral adrenal hemorrhage (anticoagulation, trauma)
• Pituitary apoplexy (secondary adrenal insufficiency)
• Critical illness in patients with subclinical insufficiency

Diagnostic Approach

🦪 Oyster: The classic electrolyte triad (hyponatremia, hyperkalemia, hypoglycemia) is present in only 50% of patients with adrenal crisis, making diagnosis challenging.

Laboratory Studies:

• Random cortisol: <15 mcg/dL suggests adrenal insufficiency
• Basic metabolic panel: Hyponatremia (Na <130), hyperkalemia (K >5.5)
• Blood glucose: Often <70 mg/dL
• Complete blood count: Eosinophilia (>4%), lymphocytosis

⚡ Clinical Hack: The "SHOCKED" assessment for adrenal crisis:

• Sodium low (<130 mEq/L)
• Hypotension (refractory to pressors)
• Oliguria
• Cortisol deficiency suspected
• Kalium (potassium) high (>5.5 mEq/L)
• Eosinophilia (>4%)
• Dextrose required for hypoglycemia

Management Protocol

🔍 Pearl #7: In suspected adrenal crisis, administer hydrocortisone immediately before obtaining confirmatory tests. The diagnostic window closes rapidly after steroid administration.

Immediate Treatment:

1. Hydrocortisone: 100-200 mg IV bolus, then 50-100 mg IV q6h
2. Fluid resuscitation: Normal saline 1-2 L rapidly
3. Electrolyte correction: Address hyperkalemia and hypoglycemia
4. Fludrocortisone: 0.1 mg daily (for primary adrenal insufficiency)

⚡ Clinical Hack: The "Rule of 100s" for adrenal crisis:

• Hydrocortisone 100 mg IV stat
• Normal saline 100 mL/hour initially
• Maintain glucose >100 mg/dL
• Continue treatment for 100 hours minimum

---

Infective Endocarditis: The Infectious Imposter

Pathophysiology

Infective endocarditis presents unique challenges as it is truly infectious but may not respond to standard sepsis protocols due to:

• Biofilm formation creating antibiotic resistance
• Embolic phenomena causing distant organ dysfunction
• Immune complex deposition leading to glomerulonephritis
• Valve destruction causing acute heart failure

Clinical Presentation

🔍 Pearl #8: New or changing cardiac murmur in a patient with septic shock mandates immediate echocardiographic evaluation, as early surgical intervention may be life-saving.

Modified Duke Criteria (2023 Update)

Major Criteria:

1. Positive blood cultures: Typical organisms in 2 separate cultures
2. Echocardiographic evidence: Vegetation, abscess, or new valve regurgitation

Minor Criteria:

1. Predisposing factors: IV drug use, prosthetic valve, congenital heart disease
2. Fever: >38°C
3. Vascular phenomena: Arterial emboli, pulmonary infarcts, Janeway lesions
4. Immunologic phenomena: Glomerulonephritis, Osler nodes, Roth spots
5. Microbiologic evidence: Positive cultures not meeting major criteria

Diagnosis: Definite = 2 major, 1 major + 3 minor, or 5 minor criteria

Diagnostic Challenges

🦪 Oyster: Culture-negative endocarditis accounts for 2.5-31% of cases and may be due to:

• HACEK organisms (Haemophilus, Aggregatibacter, Cardiobacterium, Eikenella, Kingella)
• Bartonella, Coxiella, Chlamydia species
• Prior antibiotic therapy
• Fungal endocarditis (especially in immunocompromised patients)

⚡ Clinical Hack: The "HACEK" organisms require extended culture incubation (up to 3 weeks) and special media. Alert the microbiology lab when endocarditis is suspected.

Imaging Strategy

Transthoracic Echocardiogram (TTE):

• Sensitivity: 60-70% for vegetations
• Use: Initial screening, assessment of valve function

Transesophageal Echocardiogram (TEE):

• Sensitivity: 90-95% for vegetations
• Superior for: Prosthetic valves, abscess detection, mitral valve assessment

Cardiac CT/MRI:

• Emerging role in prosthetic valve endocarditis
• Excellent for abscess and perivalvular extension

Management Approach

🔍 Pearl #9: Endocarditis requires prolonged antibiotic therapy (4-6 weeks) and often surgical intervention, unlike typical sepsis management. Early infectious disease and cardiothoracic surgery consultation is essential.

Empirical Antibiotic Therapy:

• Native valve: Vancomycin + gentamicin
• Prosthetic valve: Vancomycin + gentamicin + rifampin
• HACEK organisms: Ceftriaxone or ampicillin-sulbactam

Surgical Indications:

• Acute heart failure from valve dysfunction
• Abscess formation or conduction abnormalities
• Persistent bacteremia despite appropriate antibiotics
• Recurrent emboli despite anticoagulation
• Large vegetations (>10 mm) with embolic risk

---

Integrated Diagnostic Framework

The MIMICS Approach

To systematically evaluate suspected sepsis mimics, we propose the MIMICS framework:

Medication/exposure history (anaphylaxis, drug reactions) Immune/inflammatory markers (vasculitis, autoimmune conditions) Metabolic derangements (adrenal crisis, thyroid storm) Infectious but atypical (endocarditis, unusual organisms) Cardiac evaluation (endocarditis, cardiogenic shock) Systemic patterns (multi-organ involvement suggesting vasculitis)

Biomarker Integration

Contemporary Biomarker Panel:

• Procalcitonin: <0.5 ng/mL suggests non-bacterial etiology
• Lactate: Elevated in all forms of distributive shock
• Tryptase: Elevated in anaphylaxis (within 3 hours)
• Cortisol: <15 mcg/dL suggests adrenal insufficiency
• BNP/NT-proBNP: May be elevated in endocarditis with heart failure

⚡ Clinical Hack: The "Rule of 0.5s" for biomarker interpretation:

• Procalcitonin <0.5 ng/mL = Consider non-bacterial
• Tryptase >0.5 × upper limit normal = Consider anaphylaxis
• Cortisol <0.5 × normal morning value = Consider adrenal insufficiency

Clinical Decision Tree

Distributive Shock
        |
    Standard Sepsis Workup
        |
    Consider Mimics if:
        |
    ├── Skin findings → Vasculitis/Anaphylaxis
    ├── Refractory hypotension → Adrenal crisis
    ├── New cardiac findings → Endocarditis
    ├── Atypical organ pattern → Vasculitis
    └── Recent allergen exposure → Anaphylaxis

---

Management Pearls and Pitfalls

Universal Principles

🔍 Pearl #10: The "Bridge, Don't Burn" principle—provide supportive care while investigating, avoiding irreversible interventions until diagnosis is confirmed.

Initial Resuscitation (Common to All):

1. Airway management: Early intubation if respiratory compromise
2. Breathing support: High-flow oxygen, mechanical ventilation as needed
3. Circulation: IV access, fluid resuscitation, vasopressor support
4. Disability: Assess neurologic status, check glucose

Condition-Specific Interventions

Condition	Time-Critical Intervention	Avoid
Vasculitis	High-dose corticosteroids	Delay for biopsy
Anaphylaxis	Epinephrine IM/IV	Fluid resuscitation alone
Adrenal Crisis	Hydrocortisone IV	Delay for confirmatory tests
Endocarditis	Blood cultures × 3	Single culture set

Common Pitfalls

🦪 Oyster: Sepsis and mimics can coexist—patients with chronic immunosuppression may develop sepsis while having underlying vasculitis, or endocarditis may present with secondary septic shock.

⚡ Clinical Hack: When in doubt, treat the most immediately life-threatening condition first. You can always add or modify therapy as more information becomes available.

---

Prognosis and Outcomes

Condition-Specific Mortality

• Untreated anaphylaxis: 0.3-2% mortality (excellent prognosis with prompt epinephrine)
• Adrenal crisis: 6-26% mortality (improves dramatically with early recognition)
• Severe vasculitis: 10-50% mortality (depends on organ involvement and response to treatment)
• Endocarditis: 15-25% mortality (varies by organism and complications)

🔍 Pearl #11: Early recognition and appropriate treatment of sepsis mimics can reduce mortality to levels approaching that of appropriate sepsis management (<10% for most conditions).

Prognostic Factors

Favorable:

• Early recognition and treatment
• Absence of end-organ damage
• Responsive to initial therapy
• Younger age and fewer comorbidities

Unfavorable:

• Delayed diagnosis >24 hours
• Multi-organ failure at presentation
• Refractory shock requiring multiple vasopressors
• Significant underlying comorbidities

---

Future Directions and Research

Emerging Diagnostic Tools

Point-of-Care Testing:

• Rapid tryptase assays for anaphylaxis diagnosis
• Cortisol testing for adrenal insufficiency
• Cardiac biomarkers for endocarditis-related heart failure

Artificial Intelligence:

• Machine learning algorithms for pattern recognition
• Predictive models combining clinical and laboratory data
• Real-time decision support systems

Novel Biomarkers

Current research focuses on combinations of biomarkers including adrenomedullin, proenkephalin, and dipeptidyl peptidase 3 to improve diagnostic accuracy.

Promising Markers:

• SuPAR (soluble urokinase plasminogen activator receptor): General marker of immune activation
• Presepsin: More specific for bacterial infections than procalcitonin
• MicroRNAs: Emerging as condition-specific markers

---

Conclusion

The differential diagnosis of septic shock extends far beyond infectious etiologies to include several life-threatening conditions that require fundamentally different management approaches. The key to successful outcomes lies in maintaining diagnostic suspicion, utilizing contemporary biomarkers appropriately, and implementing condition-specific therapies rapidly.

Many of these conditions can be deadly if not diagnosed and managed appropriately, but with systematic evaluation using the MIMICS framework, early recognition of diagnostic clues, and understanding of pathophysiologic differences, critical care physicians can significantly improve patient outcomes.

The mantra "not all distributive shock is septic shock" should guide clinical decision-making. When standard sepsis management fails to improve a patient's condition, or when atypical features are present, aggressive investigation for sepsis mimics may be life-saving.

🔍 Final Pearl: Trust your clinical instincts. When something doesn't fit the typical sepsis pattern, it probably isn't sepsis. The most dangerous assumption in critical care is that shock equals sepsis.

---

Key Learning Points

1. Sepsis mimics can present with identical hemodynamic and laboratory findings to septic shock
2. Specific clinical clues and biomarker patterns can help differentiate mimics from true sepsis
3. Time-critical interventions differ dramatically between conditions (epinephrine vs. antibiotics vs. corticosteroids)
4. Systematic evaluation using the MIMICS framework improves diagnostic accuracy
5. Early recognition and condition-specific treatment can reduce mortality to <10% for most mimics
6. Coexistence of sepsis and mimics is possible, particularly in immunocompromised patients

---

References

1. Singer M, Deutschman CS, Seymour CW, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016;315(8):801-810.

2. Rudd KE, Johnson SC, Agesa KM, et al. Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the Global Burden of Disease Study. Lancet. 2020;395(10219):200-211.

3. Jennette JC, Falk RJ, Bacon PA, et al. 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum. 2013;65(1):1-11.

4. Kitchens CS. Thrombotic storm: when thrombosis begets thrombosis. Am J Med. 1998;104(4):381-385.

5. Lieberman P, Nicklas RA, Randolph C, et al. Anaphylaxis--a practice parameter update 2015. Ann Allergy Asthma Immunol. 2015;115(5):341-384.

6. Bornstein SR, Allolio B, Arlt W, et al. Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2016;101(2):364-389.

7. Hahner S, Ross RJ, Arlt W, et al. Adrenal insufficiency. Nat Rev Dis Primers. 2021;7(1):19.

8. Fowler VG Jr, Durack DT, Selton-Suty C, et al. The 2023 Duke-International Society for Cardiovascular Infectious Diseases Criteria for Infective Endocarditis: Updating the Modified Duke Criteria. Clin Infect Dis. 2023;77(4):518-526.

9. Habib G, Lancellotti P, Antunes MJ, et al. 2015 ESC Guidelines for the management of infective endocarditis. Eur Heart J. 2015;36(44):3075-3128.

10. Seymour CW, Liu VX, Iwashyna TJ, et al. Assessment of Clinical Criteria for Sepsis: For the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016;315(8):762-774.

11. Pierrakos C, Velissaris D, Bisdorff M, et al. Biomarkers of sepsis: time for a reappraisal. Crit Care. 2020;24(1):287.

12. Póvoa P, Coelho L, Almeida E, et al. C-reactive protein as a marker of infection in critically ill patients. Clin Microbiol Infect. 2005;11(2):101-108.

13. Schuetz P, Wirz Y, Sager R, et al. Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections. Cochrane Database Syst Rev. 2017;10(10):CD007498.

14. Muñoz P, Kestler M, De Alarcon A, et al. Current Epidemiology and Outcome of Infective Endocarditis: A Multicenter, Prospective, Cohort Study. Medicine (Baltimore). 2015;94(43):e1816.

15. Schwartz J, Padmanabhan A, Aqui N, et al. Guidelines on the Use of Therapeutic Apheresis in Clinical Practice-Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Seventh Special Issue. J Clin Apher. 2016;31(3):149-162.

16. Rello J, Valenzuela-Sánchez F, Ruiz-Rodriguez M, Moyano S. Sepsis: A Review of Advances in Management. Adv Ther. 2017;34(11):2393-2411.

17. Cecconi M, Evans L, Levy M, Rhodes A. Sepsis and septic shock. Lancet. 2018;392(10141):75-87.

18. Goldstein B, Giroir B, Randolph A; International Consensus Conference on Pediatric Sepsis. International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics. Pediatr Crit Care Med. 2005;6(2):2-8.

19. Iba T, Levy JH, Warkentin TE, et al. Diagnosis and management of sepsis-induced coagulopathy and disseminated intravascular coagulation. J Thromb Haemost. 2019;17(11):1989-1994.

20. Kalil AC, Metersky ML, Klompas M, et al. Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society. Clin Infect Dis. 2016;63(5):e61-e111.

---

Conflicts of Interest: The authors declare no conflicts of interest.

Funding: This work received no specific funding.